In addition to restricting iron availability, LCN2 also exerts a cytoprotective effect against STZ in a short-term HFD mouse model of diabetes by improving β-cell mass and promoting β-cell proliferation [38]. This evidence concerns the gene LCN2 and diabetes mellitus.